
|Videos|June 11, 2019
Recurrent Cutaneous Squamous Cell Carcinoma
Recurrent Cutaneous Squamous Cell Carcinoma
Advertisement
Case: A 74-Year-Old Male With Recurrent Metastatic CSCC
November 2017
- A 74-year-old male from Florida, with history of multiple resections of CSCC on neck, back and shoulders presents with new deep lesion that exhibited perineural invasion and c/o palpable left axillary mass
- Imaging confirmed 6cm left axillary nodal conglomerate
- Patient treated with neoadjuvant cisplatin/5FU for 3 cycles
- Surgical resection of primary lesion; Lymphadenectomy revealed CSCC involvement in 12 out of 16 resected lymph nodes
May 2018
- Follow-up scans revealed early disease progression with multiple pulmonary nodules
- Patient started on carboplatin/paclitaxel for 3 cycles
November 2018
- Repeat imaging showed disease progression in pulmonary nodules and multiple lymphadenopathies; mediastinal, left and right axillary; bone metastases
- Patient started on cemiplimab for 3 cycles
February 2019
- Reimaging PET-CT revealed reduction in size and metabolic activity of right and left axillary, and mediastinal lymphadenopathies; pulmonary nodules had considerable reduction in size and were no longer substantial
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
3
Imlunestrant Regimens Sustain Efficacy Benefit in ER+/HER2– Breast Cancer
4
Giredestrant/Everolimus Improves PFS Across Subgroups After CDK4/6i in ER+/HER2– Breast Cancer
5







































